We are live on
!
Find out more
Blackstone Inc Portfolio holdings
AUM
$39B
Turnover
66.05%
1-Year Est. Return
18.55%
This Fund
S&P 500
This Quarter
Est. Return
+1.57%
1 Year Est. Return
+18.55%
3 Year Est. Return
+97.25%
5 Year Est. Return
+141.78%
10 Year Est. Return
+590.31%
AUM
$31.5B
AUM Growth
+$6.55B
(+26%)
Cap. Flow
+$5.78B
Cap. Flow
% of AUM
18.33%
Top 10 Holdings %
Top 10 Hldgs %
67.04%
Holding
338
New
88
Increased
80
Reduced
39
Closed
92
Avg Time Held Equity + Options
1.3
years
Top 10 Avg Time Held Equity + Options
2.4
years
Top 20 Avg Time Held Equity + Options
2.9
years
Avg Time Held Equity only
1.3
years
Top 10 Avg Time Held Equity only
2.3
years
Top 20 Avg Time Held Equity only
2.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medline Inc
MDLN
|
+$6.04B |
| 2 |
Viper Energy
VNOM
|
+$114M |
| 3 |
Microsoft
MSFT
|
+$104M |
| 4 |
Cheniere Energy
LNG
|
+$92.6M |
| 5 |
MPLX
MPLX
|
+$88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Loar Holdings
LOAR
|
+$240M |
| 2 |
Energy Transfer Partners
ET
|
+$212M |
| 3 |
Talen Energy Corp
TLN
|
+$212M |
| 4 |
Legence Corp
LGN
|
+$127M |
| 5 |
Williams Companies
WMB
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 47% |
| 2 | Healthcare | 20.24% |
| 3 | Miscellaneous | 8.79% |
| 4 | Financials | 7.54% |
| 5 | Utilities | 5.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Viking Holdings
VIK
$37.3B
| $19.6M | 0.06% |
275,000
| – | – |
2025 Q3
1 quarter
|
|
77
South Bow Corp
SOBO
$7.24B
| $19.5M | 0.06% |
709,098
-1,461,311
| -67% | -$39.7M |
2024 Q4
4 quarters
|
|
78
DELISTED
Terns Pharmaceuticals
TERN
| $19.3M | 0.06% |
+476,754
| New | +$11M |
2025 Q4
0 quarters
|
|
79
iShares MSCI India ETF
INDA
$5.9B
| $19M | 0.06% |
350,872
| – | – |
2025 Q1
3 quarters
|
|
80
DELISTED
Liberty Broadband Class C
LBRDK
| $18.2M | 0.06% |
375,093
-53,229
| -12% | -$2.77M |
2024 Q4
4 quarters
|
|
81
Bridger Aerospace
BAER
$30.4M
| $17.6M | 0.06% |
9,624,610
| – | – |
2023 Q1
11 quarters
|
|
82
Array Technologies
ARRY
$528M
| $16.6M | 0.05% |
1,799,900
| – | – |
2021 Q3
17 quarters
|
|
83
Spyre Therapeutics
SYRE
$7.47B
| $16.4M | 0.05% |
500,998
| – | – |
2023 Q4
8 quarters
|
|
84
USA Compression Partners
USAC
$3.7B
| $16M | 0.05% |
696,709
+42,290
| +6% | +$992K |
2023 Q1
11 quarters
|
|
85
Meta Platforms (Facebook)
META
$1.81T
| $15.9M | 0.05% |
24,052
+17,898
| +291% | +$12M |
2025 Q2
2 quarters
|
|
86
Klarna Group
KLAR
$4.94B
| $15.2M | 0.05% |
525,844
-80,000
| -13% | -$2.75M |
2025 Q3
1 quarter
|
|
87
Enliven Therapeutics
ELVN
$2.73B
| $14.7M | 0.05% |
954,946
-365,646
| -28% | -$7.28M |
2024 Q1
7 quarters
|
|
88
DELISTED
Confluent
CFLT
| $14.7M | 0.05% |
+485,000
| New | +$11.9M |
2025 Q4
0 quarters
|
|
89
CRH
CRH
$55.6B
| $13.7M | 0.04% |
110,000
-340,000
| -76% | -$40.5M |
2023 Q4
8 quarters
|
|
90
Inhibikase Therapeutics
IKT
$230M
| $12.2M | 0.04% |
5,938,276
+3,300,000
| +125% | +$5.25M |
2024 Q4
4 quarters
|
|
91
Chatham Lodging
CLDT
$654M
| $11M | 0.04% |
1,621,000
| – | – |
2021 Q3
17 quarters
|
|
92
Assembly Biosciences
ASMB
$409M
| $10.8M | 0.03% |
318,754
-129,035
| -29% | -$4.16M |
2025 Q3
1 quarter
|
|
93
X4 Pharmaceuticals
XFOR
$257M
| $10.7M | 0.03% |
+2,681,922
| New | +$9.74M |
2025 Q4
0 quarters
|
|
94
FS Credit Opportunities Corp
FSCO
$1.02B
| $10.5M | 0.03% |
1,662,945
| – | – |
2024 Q4
4 quarters
|
|
95
Protara Therapeutics
TARA
$137M
| $10.2M | 0.03% |
1,909,662
| – | – |
2024 Q4
4 quarters
|
|
96
Global Partners
GLP
$1.68B
| $10.1M | 0.03% |
240,717
+13,613
| +6% | +$599K |
2023 Q1
11 quarters
|
|
97
Karbon Capital Partners Corp Units
KBONU
$314M
| $10.1M | 0.03% |
+1,000,000
| New | +$10.1M |
2025 Q4
0 quarters
|
|
98
NVIDIA
NVDA
$5.17T
| $9.63M | 0.03% |
51,630
+14,585
| +39% | +$2.71M |
2025 Q2
2 quarters
|
|
99
Lexeo Therapeutics
LXEO
$217M
| $8.99M | 0.03% |
904,959
-219,963
| -20% | -$2.01M |
2023 Q4
8 quarters
|
|
100
Genesis Energy
GEL
$1.74B
| $8.98M | 0.03% |
575,735
| – | – |
2020 Q2
22 quarters
|
|
Similar funds
Blackstone Inc's Q4 2025 Portfolio in Review
As of Q4 2025, Blackstone Inc held 338 positions worth $31.5B, up 26% from $25B the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Blackstone Inc deployed $5.78B of net new capital in Q4 2025, opening 88 new positions and adding to 80 existing holdings. Its largest new stake was Medline Inc: 142,930,404 shares worth $6B.
By sector, the portfolio is most concentrated in Energy at 47% of assets, down from 60% a quarter earlier, followed by Healthcare and Miscellaneous.
On the sell side, the largest reduction was Loar Holdings, an estimated $240M trimmed.
- Blackstone Inc's largest Q4 2025 buy was Medline Inc: 142,930,404 shares worth $6B.
- Blackstone Inc added most to Viper Energy in Q4 2025, an estimated $114M increase.
- Blackstone Inc's biggest Q4 2025 reduction was Loar Holdings, cutting an estimated $240M.
- Blackstone Inc fully exited Talen Energy Corp in Q4 2025, selling an estimated $212M.
- Blackstone Inc's ten largest holdings make up 67% of its $31.5B portfolio in Q4 2025.
- Blackstone Inc opened 88 new positions and closed 92 in Q4 2025.
- Blackstone Inc's portfolio value rose 26% quarter-over-quarter to $31.5B.
Based on Blackstone Inc's 13F filing for Q4 2025, filed 17 Feb 2026.